- Recommendation ID
- MTG46/1
- Question
Further evidence to address the uncertainties in the current clinical evidence,
including the impact of gammaCore on all treatments and care as well as its
long-term benefits, would be welcome.- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- gammaCore for cluster headache
- Number
- MTG46
- Date issued
- December 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/12/2019 |